• Reading Roadmap

  • Assessment of the 180-Day Eversense E3 CGM System in a Real-World Setting: Study 994-P
  • Key Takeaways
  • Introduction: The Eversense E3 CGM System and Its Potential Impact on Diabetes Management
  • The Eversense E3 CGM System: A Revolutionary Approach to Glucose Monitoring
  • Study 994-P: Evaluating the Eversense E3 CGM System in a Real-World Setting
  • Patient Satisfaction with the Eversense E3 CGM System
  • FAQ Section
  • What is the Eversense E3 CGM system?
  • What was the purpose of Study 994-P?
  • What were the results of Study 994-P?
  • How does the Eversense E3 CGM system work?
  • What are the benefits of the Eversense E3 CGM system?
  • Conclusion: The Future of Diabetes Management
  • Further Analysis

Assessment of the 180-Day Eversense E3 CGM System in a Real-World Setting: Study 994-P

[youtubomatic_search]

Key Takeaways

• The Eversense E3 CGM system is a revolutionary device that provides continuous glucose monitoring for up to 180 days.
• Study 994-P evaluated the performance of the Eversense E3 CGM system in a real-world setting, with promising results.
• The study found that the Eversense E3 CGM system demonstrated high accuracy and reliability in monitoring glucose levels.
• Patients reported high satisfaction rates with the device, citing its convenience and ease of use.
• The Eversense E3 CGM system could potentially transform diabetes management, offering a more convenient and reliable alternative to traditional glucose monitoring methods.

Introduction: The Eversense E3 CGM System and Its Potential Impact on Diabetes Management

Diabetes management has long been a challenge for millions of people worldwide. Traditional methods of glucose monitoring often involve frequent finger pricks and blood tests, which can be inconvenient and uncomfortable. The Eversense E3 Continuous Glucose Monitoring (CGM) system, developed by Senseonics, offers a promising alternative. This innovative device, which is implanted under the skin, provides continuous glucose monitoring for up to 180 days. Study 994-P aimed to evaluate the performance of the Eversense E3 CGM system in a real-world setting.

The Eversense E3 CGM System: A Revolutionary Approach to Glucose Monitoring

The Eversense E3 CGM system is a small, implantable device that continuously monitors glucose levels in the body. The device, which is inserted under the skin of the upper arm, uses a sensor to measure glucose levels in the interstitial fluid. These readings are then transmitted to a smartphone app, allowing users to track their glucose levels in real time. The Eversense E3 CGM system also features a unique on-body vibe alert system that notifies users of high or low glucose levels, even when their phone is not nearby.

Study 994-P: Evaluating the Eversense E3 CGM System in a Real-World Setting

Study 994-P was conducted to assess the performance of the Eversense E3 CGM system in a real-world setting. The study involved 181 participants with type 1 or type 2 diabetes, who used the device for a period of 180 days. The results of the study were highly promising. The Eversense E3 CGM system demonstrated high accuracy in monitoring glucose levels, with a Mean Absolute Relative Difference (MARD) of 9.1%. Furthermore, the device showed excellent reliability, with a sensor survival rate of 93% at 180 days.

Patient Satisfaction with the Eversense E3 CGM System

Not only did the Eversense E3 CGM system perform well in terms of accuracy and reliability, but it also received high satisfaction ratings from users. In a survey conducted as part of Study 994-P, 81% of participants reported being satisfied or very satisfied with the device. Users cited the convenience of the device, its ease of use, and the peace of mind it provided as key benefits.

FAQ Section

What is the Eversense E3 CGM system?

The Eversense E3 CGM system is a continuous glucose monitoring device that is implanted under the skin and provides glucose readings for up to 180 days.

What was the purpose of Study 994-P?

Study 994-P was conducted to evaluate the performance of the Eversense E3 CGM system in a real-world setting.

What were the results of Study 994-P?

The study found that the Eversense E3 CGM system demonstrated high accuracy and reliability in monitoring glucose levels. Users also reported high satisfaction rates with the device.

How does the Eversense E3 CGM system work?

The device uses a sensor to measure glucose levels in the interstitial fluid. These readings are then transmitted to a smartphone app, allowing users to track their glucose levels in real time.

What are the benefits of the Eversense E3 CGM system?

The Eversense E3 CGM system offers a more convenient and reliable alternative to traditional glucose monitoring methods. It also provides peace of mind to users by alerting them of high or low glucose levels.

Conclusion: The Future of Diabetes Management

The results of Study 994-P suggest that the Eversense E3 CGM system could potentially transform diabetes management. With its high accuracy, reliability, and user satisfaction rates, this innovative device offers a more convenient and reliable alternative to traditional glucose monitoring methods. As further research and development continue, the Eversense E3 CGM system could become a standard tool in diabetes management, improving the quality of life for millions of people worldwide.

[youtubomatic_search]

Further Analysis

While the results of Study 994-P are promising, further research is needed to confirm the long-term effectiveness and safety of the Eversense E3 CGM system. Future studies should also explore the impact of the device on glycemic control and diabetes-related complications. Nevertheless, the Eversense E3 CGM system represents a significant step forward in diabetes management, offering hope for a future where managing this chronic condition is less burdensome and more effective.